News

iZafe Group Presents at the “Stora Aktiedagarna”

STOCKHOLM, SWEDEN / ACCESSWIRE / November 28, 2023 / iZafe Group (STO:IZAFE-B) (publ.) hereby announces that CEO Anders Segerström will…

1 year ago

Royal Biologics Announces Commerical Launch of Derm-Maxx(TM) and Newly Formed Wound Care Division

HACKENSACK, NJ / ACCESSWIRE / November 28, 2023 / Royal Biologics, Inc., a company specializing in Advanced Cellular & Autologous…

1 year ago

NLS Pharmaceutics Announces Election of Additional Board Members

Professor Claudio L. A. Bassetti, MD, is the Chair, Neurology Department, Inselspital, Bern University Hospital and Dean, Medical Faculty, University…

1 year ago

Infinx Healthcare Named as Representative Vendor in Gartner’s Market Guide for Intelligent Prior Authorization, U.S. Healthcare Organizations

Research firm Gartner recognizes Infinx Healthcare in their first ever Market Guide for Intelligent Prior Authorization for U.S. healthcare organizations.NEW…

1 year ago

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

ORLANDO, FL / ACCESSWIRE / November 28, 2023 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today…

1 year ago

The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, Has Successfully Completed the First Part (Phase 1a), Reports NanoViricides

SHELTON, CT / ACCESSWIRE / November 28, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development…

1 year ago

Zomedica to Present at Noble Capital Markets’ 19th Annual Emerging Growth Equity Conference

ANN ARBOR, MI / ACCESSWIRE / November 28, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

1 year ago

SciSparc Adopts Limited Duration Shareholder Rights Plan

TEL AVIV, Israel, Nov. 28, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical…

1 year ago

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

LEXINGTON, Ky. and ST. LOUIS, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for…

1 year ago